Dare Bioscience Competitors and Similar CompaniesClear all
Dare Bioscience's competitors and similar companies include NexImmune.
 Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. |  NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | |
Founding Date | Founding Date 2006 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Gaithersburg, US HQ |
Employees | Employees 980% increase | Employees 5032% decrease |
Valuation ($) | Valuation ($) 33.8 m | Valuation ($) 372.4 k |
Financial | ||
Net income | Net income ($13.4m) (FY, 2025) | Net income ($32.3m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 115.7m | Total funding raised $ 33.8m |
For sources of this data, please see the company profile
View Company Profiles
NexImmune
HQ
Gaithersburg, US
Employees
50↓ 32% decrease
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company